GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients

Lihua Yu(Zhujiang Hospital), Lihua Yang(Second Affiliated Hospital of Nanjing Medical University), Guanmei Zhang(Zhujiang Hospital), Lulu Huang(Royal Netherlands Academy of Arts and Sciences), Lichan Liang(Zhujiang Hospital), Yinghua Zeng(Nanfang Hospital), Danna Lin(Zhujiang Hospital), Yuchen Liu(Fudan University), Bin Wang(Zhongda Hospital Southeast University), Jiale Liu(Zhujiang Hospital), Shaohua Tao(Zhujiang Hospital), Cheng Jiao(Shenzhen Genoimmune Medical Institute), Xu Liao(Zhujiang Hospital), Xiaorong Lai(Zhujiang Hospital), Lung‐Ji Chang(University of Florida), Li Wu(Zhujiang Hospital), Wu Zhu(Zhujiang Hospital)
Journal of Cancer Research and Clinical Oncology
November 1, 2021
Cited by 84


Related Papers